Lv6
2020 积分 2021-03-04 加入
Targeting lysosomal dysfunction with small-molecule TRPML1 ligands: Therapeutic opportunities in lysosomal storage disorders, neurodegeneration and beyond
12天前
已完结
Patient-Reported Symptom Burden in Individuals With Parkinson Disease
12天前
已完结
Discovery of Selective Inhibitors for the Lysosomal Parkinson’s Disease Channel TMEM175
28天前
已完结
High concentration electrophysiology-based fragment screen: Discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitors
28天前
已完结
Mechanisms of autophagy–lysosome dysfunction in neurodegenerative diseases
30天前
已完结
Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen
4个月前
已完结
Ambroxol for Parkinson's Disease
4个月前
已完结
An open-label phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 Gangliosidosis (Tay-Sachs or Sandhoff variants)
4个月前
已完结
Modeling Parkinson’s disease pathology in human dopaminergic neurons by sequential exposure to α-synuclein fibrils and proinflammatory cytokines
4个月前
已完结
Real-time measurement of the ATG8 lipidation reaction by fluorescence spectroscopy
4个月前
已关闭
皖公网安备34019202002308
